National cross-sectional survey of 1.14 million NHS staff SARS-CoV-2 serology tests: a comparison of NHS staff with regional community seroconversion rates

Objectives An initial report of findings from 1.14 million SARS CoV-2 serology tests in National Health Service (NHS) staff to compare NHS staff seroconversion with community seroconversion rates at a regional level. Design A national cross-sectional survey. Setting A SARS-CoV-2 antibody testing programme offered across all NHS Trusts. Participants 1.14 million NHS staff. Intervention SARS-CoV-2 antibody testing. Primary and secondary outcome measures SARS-CoV-2 antibody testing was used to estimate the seroprevalence of SARS-CoV-2 in NHS staff by region, compared with community seroprevalence as determined by the COVID-19 Infection Survey (Office for National Statistics). We also explored seroprevalence trends by regional COVID-19 activity, using regional death rates as a proxy for COVID-19 ‘activity’. Results 1 146 310 tests were undertaken on NHS staff between 26 May and 31 August 2020. 186 897 NHS tests were positive giving a seroconversion rate of 16.3% (95% CI 16.2% to 16.4%), in contrast to the national community seroconversion rate of 5.9% (95% CI 5.3% to 6.6%). There was significant geographical regional variation, which mirrored the trends seen in community prevalence rates. NHS staff were infected at a higher rate than the general population (OR 3.1, 95% CI 2.8 to 3.5). NHS seroconversion by regional death rate suggested a trend towards higher seroconversion rates in the areas with higher COVID-19 ‘activity’. Conclusions This is the first cross-sectional survey assessing the risk of COVID-19 disease in healthcare workers at a national level. It is the largest study of its kind. It suggests that NHS staff have a significantly higher rate of COVID-19 seroconversion compared with the general population in England, with regional variation across the country which matches the background population prevalence trends. There was also a trend towards higher seroconversion rates in areas which had experienced high COVID-19 clinical activity. This work has global significance in terms of the value of such a testing programme and contributing to the understanding of healthcare worker seroconversion at a national level.

[1]  E. Vynnycky,et al.  The impact of testing and infection prevention and control strategies on within-hospital transmission dynamics of COVID-19 in English hospitals , 2020, Philosophical Transactions of the Royal Society B.

[2]  H. Tegel,et al.  SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden , 2020, Nature Communications.

[3]  M. Drayson,et al.  SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study , 2020, Thorax.

[4]  R. Manuel,et al.  Nosocomial COVID-19: experience from a large acute NHS Trust in South-West London , 2020, Journal of Hospital Infection.

[5]  D. Stuart,et al.  Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study , 2020, eLife.

[6]  Mark S. Anderson,et al.  Test performance evaluation of SARS-CoV-2 serological assays , 2020, Nature biotechnology.

[7]  H. Ullum,et al.  Risk of COVID-19 in health-care workers in Denmark: an observational cohort study , 2020, The Lancet Infectious Diseases.

[8]  M. Jorge Cardoso,et al.  Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study , 2020, The Lancet Public Health.

[9]  M. Rayment,et al.  Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study , 2020, The Lancet Respiratory Medicine.

[10]  J. Hewitt,et al.  Nosocomial COVID-19 infection: examining the risk of mortality. The COPE-Nosocomial Study (COVID in Older PEople) , 2020, Journal of Hospital Infection.

[11]  R. Peeling,et al.  Serology testing in the COVID-19 pandemic response , 2020, The Lancet Infectious Diseases.

[12]  Robert L. Goldstone,et al.  Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers , 2020, The Lancet.

[13]  C. Houlihan,et al.  Nosocomial transmission of COVID-19: a retrospective study of 66 hospital-acquired cases in a London teaching hospital , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  Kenneth G. C. Smith,et al.  Effective control of SARS-CoV-2 transmission between healthcare workers during a period of diminished community prevalence of COVID-19 , 2020, eLife.

[15]  V. Torri,et al.  IgG serology in health care and administrative staff populations from 7 hospital representative of different exposures to SARS-CoV-2 in Lombardy, Italy , 2020, medRxiv.

[16]  Mengjia Wang,et al.  Analysis of the Infection Status of Healthcare Workers in Wuhan During the COVID-19 Outbreak: A Cross-sectional Study , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  William L. Hamilton,et al.  Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission , 2020, medRxiv.

[18]  D. Lendrem,et al.  First experience of COVID-19 screening of health-care workers in England , 2020, The Lancet.

[19]  C. E..  WHO Coronavirus Disease (COVID-19) Dashboard , 2020 .

[20]  A. Nienhaus,et al.  The Occupational Risk of Influenza A (H1N1) Infection among Healthcare Personnel during the 2009 Pandemic: A Systematic Review and Meta-Analysis of Observational Studies , 2016, PloS one.

[21]  Anne M Johnson,et al.  Role of healthcare workers in early epidemic spread of Ebola: policy implications of prophylactic compared to reactive vaccination policy in outbreak prevention and control , 2015, BMC Medicine.

[22]  J. Bresee,et al.  Ebola Virus Disease in Health Care Workers — Sierra Leone, 2014 , 2014, MMWR. Morbidity and mortality weekly report.

[23]  P. Shah,et al.  Incidence of Influenza in Healthy Adults and Healthcare Workers: A Systematic Review and Meta-Analysis , 2011, PloS one.

[24]  J. A. Comer,et al.  Lack of SARS transmission and U.S. SARS case-patient. , 2004, Emerging infectious diseases.

[25]  J. A. Comer,et al.  Lack of SARS Transmission among Healthcare Workers, United States , 2004, Emerging infectious diseases.

[26]  Philip M. Long,et al.  Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection , 2003, The Lancet.

[27]  Peter Cameron,et al.  A major outbreak of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.